title: Hepatoblastoma in children: a review.
abstract: The past 25 years have seen a dramatic improvement in results of treatment of children with HBL; formerly, < 25% were cured, and today, 65 to 75% may be cured. New, active agents are still needed, and the late effects of therapy, especially on the heart and kidneys, remain a concern. Nevertheless, it is clear that treatment of HBL is indeed "a bit of a success story" (42).
authors.affiliation: Department of Pediatrics, M.D. Anderson Cancer Center, University of Texas, Houston, Texas 77030, USA.
authors.forename: B
authors.initials: B
authors.lastname: Raney
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D018197:Hepatoblastoma / Q000453:epidemiology / Q000209:etiology / Q000235:genetics / Q000628:therapy*; D006801:Humans; D015994:Incidence; D008113:Liver Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000235:genetics / Q000628:therapy*; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents